These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Steady-state and transient kinetic analyses of taurine/alpha-ketoglutarate dioxygenase: effects of oxygen concentration, alternative sulfonates, and active-site variants on the FeIV-oxo intermediate. Grzyska PK; Ryle MJ; Monterosso GR; Liu J; Ballou DP; Hausinger RP Biochemistry; 2005 Mar; 44(10):3845-55. PubMed ID: 15751960 [TBL] [Abstract][Full Text] [Related]
28. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. Lee C; Kim SJ; Jeong DG; Lee SM; Ryu SE J Biol Chem; 2003 Feb; 278(9):7558-63. PubMed ID: 12482756 [TBL] [Abstract][Full Text] [Related]
30. Crystal structures of human FIH-1 in complex with quinol family inhibitors. Moon H; Han S; Park H; Choe J Mol Cells; 2010 May; 29(5):471-4. PubMed ID: 20396966 [TBL] [Abstract][Full Text] [Related]
31. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α. Kang J; Chun YS; Huh J; Park JW Redox Biol; 2018 Oct; 19():364-374. PubMed ID: 30237125 [TBL] [Abstract][Full Text] [Related]
32. Stopped-flow kinetic analysis of Escherichia coli taurine/alpha-ketoglutarate dioxygenase: interactions with alpha-ketoglutarate, taurine, and oxygen. Ryle MJ; Padmakumar R; Hausinger RP Biochemistry; 1999 Nov; 38(46):15278-86. PubMed ID: 10563813 [TBL] [Abstract][Full Text] [Related]
33. Featured Article: Hypoxia-inducible factor-1α dependent nuclear entry of factor inhibiting HIF-1. Liang K; Ding XQ; Lin C; Kang YJ Exp Biol Med (Maywood); 2015 Nov; 240(11):1446-51. PubMed ID: 25687434 [TBL] [Abstract][Full Text] [Related]
34. Regulation of Transactivation at C-TAD Domain of HIF-1 Rani S; Roy S; Singh M; Kaithwas G Oxid Med Cell Longev; 2022; 2022():2407223. PubMed ID: 35592530 [TBL] [Abstract][Full Text] [Related]
36. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740 [TBL] [Abstract][Full Text] [Related]
37. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression. Hyseni A; van der Groep P; van der Wall E; van Diest PJ Cell Oncol (Dordr); 2011 Dec; 34(6):565-70. PubMed ID: 21732131 [TBL] [Abstract][Full Text] [Related]
38. MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH). Webb JD; Murányi A; Pugh CW; Ratcliffe PJ; Coleman ML Biochem J; 2009 May; 420(2):327-33. PubMed ID: 19245366 [TBL] [Abstract][Full Text] [Related]
39. The rate-limiting step of O2 activation in the α-ketoglutarate oxygenase factor inhibiting hypoxia inducible factor. Hangasky JA; Gandhi H; Valliere MA; Ostrom NE; Knapp MJ Biochemistry; 2014 Dec; 53(51):8077-84. PubMed ID: 25423620 [TBL] [Abstract][Full Text] [Related]
40. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Mahon PC; Hirota K; Semenza GL Genes Dev; 2001 Oct; 15(20):2675-86. PubMed ID: 11641274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]